ELVN

Enliven Therapeutics is a drug development company working on cancer treatments. The company is testing two experimental medications: one designed to treat a blood cancer called chronic myeloid leukemia, and another intended to treat certain types of lung cancer and other tumors. Both drugs are still in early testing stages in human patients. The company was founded in 2019 and is based in Boulder, Colorado.